Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,181.00    -12.50 (-1.05%)
Bid:
1,178.50
Ask:
1,179.50
Spread: 1.00 (0.085%)
Market Cap: £6.01b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

25 Oct 2017 09:23

St. James’s Place plc (β€œSJP”)

SJP was notified on 24 October 2017 of the following changes in SJP shares held by the Executive Directors named below.

SJP Performance Share Plan 2005 (β€œPSP”) and linked Company Share Option Plan 2010 (β€œCSOP”)

CSOP

On 26 March 2014 the following Executive Directors (β€œthe Directors”) were awarded a CSOP-linked award, whereby they were granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC-approved CSOP share option:

Andrew Croft, Chief Financial Officer

Ian Gascoigne, Managing Director

David Lamb, Managing Director

The Directors exercised the linked CSOP award on 24 October 2017 with an exercise price of Β£8.515 per share and, as a result, their linked PSP awards automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 24 October 2017, and column 2 sets out the number of SJP shares sold on 24 October 2017 at Β£11.81 pence per share by the Directors. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of these exercises, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

CSOP 1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SJP shares retained under the linked PSP award
Andrew Croft 3,054 3,054 853 72,312
Ian Gascoigne 3,054 2,632 853 72,312
David Lamb 3,054 3,054 853 72,312

PSP

On 26 March 2014 the Directors were awarded nil cost unapproved PSP awards. On 24 October 2017 the Directors exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 24 October 2017 at a price of Β£11.72 pence per share by the Directors in order to settle income tax and National Insurance liabilities, and column 3 sets out the number of additional SJP shares sold by the Directors at Β£11.72. Column 4 sets out the number of SJP shares retained.

PSP 1 2 3 4
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of Additional SJP Shares Sold Number of SJP shares retained
Andrew Croft 72,312 33,987 19,210 19,115
Ian Gascoigne 72,312 33,987 19,210 19,115
David Lamb 72,312 33,987 38,325 0

Following the above transactions, Ian Gascoigne gifted at nil cost 19,537 SJP shares to Gail Gascoigne, a Person Closely Associated with him, on 24 October 2017.

This notification is made in accordance with EU Market Abuse Regulation.

LEI: 213800M993ICXOMBCP87

Classification: 3.1 Additional regulated information required to be disclosed under the laws of a Member State

Deputy Company Secretary, Tel: +44 (0)1285 717237

25 October 2017

View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005470/en/

Copyright Business Wire 2017

Date   Source Headline
22nd Oct 20197:00 amRNSQ3 New Business Inflows and Funds under Management
17th Oct 20194:35 pmRNSHolding(s) in Company
17th Oct 20192:20 pmRNSDirectorate Change
2nd Oct 20195:24 pmRNSHolding(s) in Company
1st Oct 201912:42 pmRNSTotal Voting Rights
17th Sep 201910:26 amRNSHolding(s) in Company
13th Sep 20199:45 amRNSHolding(s) in Company
13th Sep 20199:45 amRNSHolding(s) in Company
12th Sep 20193:00 pmRNSHolding(s) in Company
3rd Sep 20199:30 amRNSTotal Voting Rights
16th Aug 20192:30 pmRNSHolding(s) in Company
13th Aug 20198:46 amRNSHolding(s) in Company
2nd Aug 20199:14 amRNSDirector/PDMR Shareholding
1st Aug 20195:32 pmRNSBlock listing Interim Review
1st Aug 20194:19 pmRNSHolding(s) in Company
1st Aug 20194:01 pmRNSTotal Voting Rights
31st Jul 201912:16 pmRNSHolding(s) in Company
31st Jul 201912:16 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSInterim Statement for the 6 Months to 30 June 2019
19th Jul 201912:06 pmRNSHolding(s) in Company
18th Jul 20194:18 pmRNSHolding(s) in Company
16th Jul 20192:38 pmRNSHolding(s) in Company
9th Jul 20192:57 pmRNSHolding(s) in Company
8th Jul 20199:54 amRNSHolding(s) in Company
5th Jul 20191:12 pmRNSHolding(s) in Company
5th Jul 201912:39 pmRNSHolding(s) in Company
4th Jul 201910:20 amRNSHolding(s) in Company
3rd Jul 20195:07 pmRNSHolding(s) in Company
3rd Jul 20194:57 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 201911:39 amRNSHolding(s) in Company
1st Jul 20192:35 pmRNSTotal Voting Rights
28th Jun 201910:35 amRNSHolding(s) in Company
27th Jun 20195:00 pmRNSHolding(s) in Company
25th Jun 20193:58 pmRNSHolding(s) in Company
25th Jun 201912:17 pmRNSHolding(s) in Company
25th Jun 201912:08 pmRNSHolding(s) in Company
24th Jun 20193:37 pmRNSHolding(s) in Company
24th Jun 20193:27 pmRNSHolding(s) in Company
24th Jun 20192:42 pmRNSNotification of Major Holdings
24th Jun 20192:39 pmRNSHolding(s) in Company
24th Jun 20192:37 pmRNSHolding(s) in Company
24th Jun 201911:10 amRNSHolding(s) in Company
21st Jun 20195:51 pmRNSHolding(s) in Company
21st Jun 20195:46 pmRNSHolding(s) in Company
21st Jun 20194:38 pmRNSHolding(s) in Company
21st Jun 20194:38 pmRNSHolding(s) in Company
21st Jun 20193:49 pmRNSHolding(s) in Company
21st Jun 20193:42 pmRNSHolding(s) in Company
21st Jun 20193:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.